Biomarker Test Granted Breakthrough Device Status & Intermittent Catheterization With a Wheelchair

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how a blood test for the multiple sclerosis biomarker, neurofilament light chain, has been granted breakthrough device designation by the FDA.

He also reads “The Tricks of Intermittent Catheterization When You’re in a Wheelchair” a column by John Connor.

===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/